The FDA Commissioner on Vaccines and Public Trust

Ryan Knutson interviews FDA Commissioner Dr. Marty Makary about vaccine policy, the FDA's role, and public trust in health institutions. Makary discusses the FDA's risk-stratified approach to COVID booster approvals, emphasizing the need for clinical trial data and addressing concerns about vaccine safety. He defends the decision to narrow booster recommendations, criticizes the CDC's vaccine advisory committee, and advocates for open scientific discourse. Makary also mentions an ongoing investigation into reported deaths following COVID vaccination in children and announces increased enforcement against misleading pharmaceutical advertising.